Biography
Prof. Michał Pikuła is a specialist in regenerative medicine, tissue engineering, and experimental dermatology. He previously served as Principal Investigator and group leader in several completed research projects, including a National Science Centre- funded projects. He was also the team leader in two research consortia: BIONANOVA, focused on nanomaterials for tissue engineering, and Regennova, which developed innovative regenerative therapies based on bioactive compounds.
Currently, Prof. Michał Pikuła leads a research team at the Medical University of Gdańsk (MUG), including a dedicated group working within the GreenNanoBone project (“Sustainable 4D hydrogels functionalised with plant-based nanoparticles for bone regeneration in cancer patients,” 2025–2029), funded by the European Commission under the Horizon Europe programme. In addition to his research activities, Prof. Pikuła teaches both medical and doctoral students and currently serves as Deputy Director of the First Doctoral School at MUG.
Title of presentation:
Adipose-derived mesenchymal stromal cells (AD-MSCs) as a versatile tool in regenerative medicine and drug screening models
Highlights:
Michał Pikuła, MSc, PhD is a Professor at the Laboratory of Tissue Engineering and Regenerative Medicine, Dpt. of Embryology, at the Medical University of Gdansk (MUG), Poland and also a Professor at the Dpt. of Biochemistry, at the University of Physical Education and Sport, Gdansk. He completed his M.Sc. from University of Gdansk (Molecular biology, 2003), M. Pharm. from Medical University of Gdansk (Pharmacy Practice, 2005), and his PhD in medical biology from Medical University of Gdansk (specialty cell biology, 2007). He is a Professor of medical sciences and health sciences (title, 2020). In addition to his scientific and academic training, he also completed Postgraduate Management Studies in Company Management in Health Care at the Gdańsk University of Technology (2011).